These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 11058037

  • 1. A practical synthesis of the serotonin 5-HT2A receptor antagonist MDL 100907, its enantiomer and their 3-phenolic derivatives as precursors for [11C]labeled PET ligands.
    Ullrich T, Rice KC.
    Bioorg Med Chem; 2000 Oct; 8(10):2427-32. PubMed ID: 11058037
    [Abstract] [Full Text] [Related]

  • 2. [11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography.
    Lundkvist C, Halldin C, Ginovart N, Nyberg S, Swahn CG, Carr AA, Brunner F, Farde L.
    Life Sci; 1996 Oct; 58(10):PL 187-92. PubMed ID: 8602111
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain.
    Andrée B, Nyberg S, Ito H, Ginovart N, Brunner F, Jaquet F, Halldin C, Farde L.
    J Clin Psychopharmacol; 1998 Aug; 18(4):317-23. PubMed ID: 9690698
    [Abstract] [Full Text] [Related]

  • 6. Time course of 5-HT2A receptor occupancy in the human brain after a single oral dose of the putative antipsychotic drug MDL 100,907 measured by positron emission tomography.
    Gründer G, Yokoi F, Offord SJ, Ravert HT, Dannals RF, Salzmann JK, Szymanski S, Wilson PD, Howard DR, Wong DF.
    Neuropsychopharmacology; 1997 Sep; 17(3):175-85. PubMed ID: 9272484
    [Abstract] [Full Text] [Related]

  • 7. Investigation of the CNS penetration of a potent 5-HT2a receptor antagonist (MDL 100,907) and an active metabolite (MDL 105,725) using in vivo microdialysis sampling in the rat.
    Scott DO, Heath TG.
    J Pharm Biomed Anal; 1998 May; 17(1):17-25. PubMed ID: 9608422
    [Abstract] [Full Text] [Related]

  • 8. Kinetic analysis of the 5-HT2A ligand [11C]MDL 100,907.
    Watabe H, Channing MA, Der MG, Adams HR, Jagoda E, Herscovitch P, Eckelman WC, Carson RE.
    J Cereb Blood Flow Metab; 2000 Jun; 20(6):899-909. PubMed ID: 10894173
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [3H]MDL 100,907: a novel selective 5-HT2A receptor ligand.
    Johnson MP, Siegel BW, Carr AA.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):205-9. PubMed ID: 8857599
    [Abstract] [Full Text] [Related]

  • 12. The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis.
    Carlsson ML.
    J Neural Transm Gen Sect; 1995 Jul; 100(3):225-37. PubMed ID: 8748668
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT2A receptor (5-HT2AR) antagonist M100907.
    Gilbertson SR, Chen YC, Soto CA, Yang Y, Rice KC, Cunningham KA, Anastasio NC.
    Bioorg Med Chem Lett; 2018 May 01; 28(8):1381-1385. PubMed ID: 29555153
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development of novel chiral capillary electrophoresis methods for the serotonin receptor (5-HT2A) antagonist MDL 100,907 (volinanserin) and for its key intermediate compound.
    Németh K, Palkó R, Kovács P, Visy J.
    J Pharm Biomed Anal; 2014 Jan 01; 88():579-83. PubMed ID: 24216279
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.
    Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F.
    Bioorg Med Chem; 2009 Apr 15; 17(8):2989-3002. PubMed ID: 19329329
    [Abstract] [Full Text] [Related]

  • 20. Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907.
    Hall H, Farde L, Halldin C, Lundkvist C, Sedvall G.
    Synapse; 2000 Dec 15; 38(4):421-31. PubMed ID: 11044889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.